Cite
HARVARD Citation
Curry, M. et al. (2017). Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients. Alimentary pharmacology & therapeutics. 46 (5), pp. 540-548. [Online].